Literature DB >> 27886644

Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy.

Chung-Hsiung Huang1, Chia-Chi Wang2, Yu-Chin Lin3, Masatoshi Hori4, Tong-Rong Jan5.   

Abstract

Although the development of T helper (Th)1-like regulatory T (Treg) cells under Th1 inflammatory conditions has been reported, the role of Th1-like Treg cells in Th2 allergic responses remains mostly unclear. We previously demonstrated that diosgenin, the major sapogenin contained in the Chinese yam, attenuated food allergy and augmented Th1 and Treg immune responses. In this study, we hypothesized that diosgenin may enhance the induction of Th1-like Treg cells in the gut of mice with food allergy. Ovalbumin (OVA)-sensitized BALB/c mice were gavaged daily with diosgenin and received repeatedly intragastric ovalbumin challenges to induce intestinal allergic responses. The induction of Foxp3+ Treg cells co-expressing Th1-type transcription factors, cytokines and chemokines in the intestine was examined, and the mRNA expression of the chemokines corresponding to Th1-like Treg cells was measured. Diosgenin administration increased the number of Foxp3+ Treg cells co-expressing Th1 markers, including CCR5, CXCR3, IFN-γ and T-bet in the intestine, and enhanced populations of Foxp3+IFN-γ+ and Foxp3+T-bet+ cells that expressed the regulatory cytokine IL-10 in the Peyer's patches. Diosgenin also augmented the intestinal expression of CXCR3, CCL3, and CXCL10. Concordantly, diosgenin increased the number of CXCR3+Foxp3+IL-10 cells in the Peyer's patches. Our data demonstrated the enhanced induction of Th1-like Treg cells in allergic mice treated with diosgenin, providing evidence to suggest a role for Th1-like Treg cells in diosgenin-mediated anti-allergic effects against Th2-type allergy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diosgenin; Food allergy; Intestine; Th1-like Treg cell; Th2-type

Mesh:

Substances:

Year:  2016        PMID: 27886644     DOI: 10.1016/j.intimp.2016.11.021

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  6 in total

1.  Diosgenin inhibits the epithelial-mesenchymal transition initiation in osteosarcoma cells via the p38MAPK signaling pathway.

Authors:  Huaming Huang; Chao Nie; Xiaokang Qin; Jie Zhou; Lei Zhang
Journal:  Oncol Lett       Date:  2019-08-23       Impact factor: 2.967

Review 2.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 3.  Outstanding animal studies in allergy I. From asthma to food allergy and anaphylaxis.

Authors:  Erika Jensen-Jarolim; Isabella Pali-Schöll; Franziska Roth-Walter
Journal:  Curr Opin Allergy Clin Immunol       Date:  2017-06

4.  An update on the biological and pharmacological activities of diosgenin.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2018-01-02       Impact factor: 4.068

5.  Influence of different erythrocyte storage times on the macrophage response in haemorrhagic shock mice.

Authors:  Zhen-Zhou Li; Xiao-Xiao Wang; Li Ma; Huan Wang; Jia-Ming Xu; Xiao-Fang Zhou; Yang Liu; Jian-Rong Guo
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

Review 6.  Emerging immune and cell death mechanisms in stroke: Saponins as therapeutic candidates.

Authors:  Laura García-Pupo; Emily Van San; René Delgado-Hernández; Tom Vanden Berghe; Wim Vanden Berghe
Journal:  Brain Behav Immun Health       Date:  2020-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.